GSK-3β inhibitor 20

GSK-3β inhibitor 20 (compound 3A) is an potent inhibitor of GSK-3β with an IC50 value of 74.4 nM[1].

Product Specifications

CAS Number

[3044109-48-7]

UNSPSC

12352211

Target

GSK-3

Type

Reference compound

Related Pathways

PI3K/Akt/mTOR; Stem Cell/Wnt

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/gsk-3β-inhibitor-20.html

Smiles

O=C(NC1=CC=CC=C1)NC2=CC(C3=CC(NN=C4NC(C(C)C)=O)=C4S3)=CC=C2

Molecular Formula

C22H21N5O2S

Molecular Weight

419.50

References & Citations

[1]Ning Yan, et al. Design, synthesis and biological evaluation of thieno[3,2-c]pyrazol-urea derivatives as potent glycogen synthase kinase 3β inhibitors based on the DFG-out conformation. Bioorg Med Chem Lett. 2024 Nov 1:112:129932.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

10215 96 Tests

Acetylcholine (ACH) Human ELISA Kit

View Details

NBP2-90668G 0.1 mL

Rabbit Monoclonal Caspr2 Antibody (001) [DyLight 488]

View Details

SR300371 1 Kit

ATP6V1G2 Human siRNA Oligo Duplex (Locus ID 534)

View Details

STJ110802 100 µl

Anti-MKL1 antibody

View Details

MBS6221808-01 0.1 mL

DGCR8 (Microprocessor Complex Subunit DGCR8, DiGeorge Syndrome Critical Region 8, C22orf12, DGCRK6, LP4941) (MaxLight 650)

View Details

MBS6221808-02 5x 0.1 mL

DGCR8 (Microprocessor Complex Subunit DGCR8, DiGeorge Syndrome Critical Region 8, C22orf12, DGCRK6, LP4941) (MaxLight 650)

View Details